"attachment_1199068" align="aligncenter" width="1456"] A pharmacy worker distributing prescription medicines to ...

The claim about his health and the COVID-19 vaccine is consistent with a common conspiracy theory that spread online during the pandemic, falsely attributing numerous famous peoples' deaths to the ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

This week's episode covers news about Sarepta, babies born following mitochondrial transfer, and AI identifying therapy targets.

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, & Head of Development starting Aug 2025.

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...